The store will not work correctly when cookies are disabled.
1-(4-bromophenyl)-6-(2-isopropoxyphenyl)-5H-pyrazolo[3,4-d]pyrimidin-4-one
ID: ALA4777918
PubChem CID: 162644258
Max Phase: Preclinical
Molecular Formula: C20H17BrN4O2
Molecular Weight: 425.29
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: CC(C)Oc1ccccc1-c1nc2c(cnn2-c2ccc(Br)cc2)c(=O)[nH]1
Standard InChI: InChI=1S/C20H17BrN4O2/c1-12(2)27-17-6-4-3-5-15(17)18-23-19-16(20(26)24-18)11-22-25(19)14-9-7-13(21)8-10-14/h3-12H,1-2H3,(H,23,24,26)
Standard InChI Key: MWZHPPQRBJHFTB-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
11.6192 -6.3584 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3334 -5.9476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.0437 -6.3579 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0437 -7.1803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3318 -7.5903 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.6192 -7.1855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.8335 -7.4393 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.3493 -6.7718 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
10.8335 -6.1046 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.6184 -8.2383 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.2021 -8.8225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9911 -9.6176 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.1918 -9.8328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.6105 -9.2506 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.8188 -8.4547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9767 -10.6277 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
13.7576 -7.5936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4718 -7.1805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1862 -7.5931 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1862 -8.4203 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4743 -8.8327 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.7576 -8.4256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.4718 -6.3537 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
15.1898 -5.9402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1898 -5.1134 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9037 -6.3537 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3334 -5.1208 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
5 4 2 0
6 5 1 0
1 6 2 0
6 7 1 0
7 8 1 0
8 9 2 0
1 9 1 0
10 7 1 0
11 10 2 0
12 11 1 0
13 12 2 0
14 13 1 0
15 14 2 0
10 15 1 0
13 16 1 0
17 4 1 0
18 17 2 0
19 18 1 0
20 19 2 0
21 20 1 0
22 21 2 0
17 22 1 0
18 23 1 0
23 24 1 0
24 25 1 0
24 26 1 0
2 27 2 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 425.29 | Molecular Weight (Monoisotopic): 424.0535 | AlogP: 4.33 | #Rotatable Bonds: 4 |
Polar Surface Area: 72.80 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 8.88 | CX Basic pKa: ┄ | CX LogP: 4.19 | CX LogD: 4.17 |
Aromatic Rings: 4 | Heavy Atoms: 27 | QED Weighted: 0.53 | Np Likeness Score: -1.68 |
References
1. Shaaban MA,Elshaier YAMM,Hammad AH,Farag NA,Hassan Haredy H,AbdEl-Ghany AA,Mohamed KO. (2020) Design and synthesis of pyrazolo[3,4-d]pyrimidinone derivatives: Discovery of selective phosphodiesterase-5 inhibitors., 30 (16): [PMID:32631538] [10.1016/j.bmcl.2020.127337] |